Matrix Service Company (MTRX) Q3 2025 Earnings Call May 08, 2025 10:30 AM ET Company Participants Kellie Smythe - Senior Director of Investor RelationsJohn Hewitt - CEO, President & DirectorKevin Cavanah - VP of Finance, CFO & Treasurer Conference Call Participants John Franzreb - Senior Equity AnalystBrent Thielman - MD & Senior Research Analyst Operator Good morning, and welcome to the Matrix Service Company Conference Call to discuss Results for the Third Quarter of Fiscal twenty twenty five. Currently, ...

Financial Data and Key Metrics Changes - Revenue for Q3 2025 increased by 21% to $200.2 million compared to $166 million in Q3 2024, driven by growth in storage and utility segments [21][31] - Gross margin improved to $12.9 million or 6.4% in Q3 2025 from $5.6 million or 3.4% in Q3 2024 [21][22] - The company reported a net loss of $3.4 million or $0.12 per share, an improvement from a net loss of $14.6 million or $0.53 per share in the same quarter last year [23] Business Line Data and Key Metrics Changes - Storage and Thermal Solutions segment revenue surged by 77% to $96.1 million in Q3 2025 from $54.3 million in Q3 2024, driven by specialty vessel projects [23][24] - Utility and Power Infrastructure segment revenue rose by 27% to $58.7 million compared to $46.1 million in the prior year, benefiting from natural gas peak shaving projects [25] - Process and Industrial Facilities segment revenue decreased to $45.4 million from $65.6 million, primarily due to the completion of a large renewable diesel project [26] Market Data and Key Metrics Changes - The company anticipates a 45% increase in U.S. LNG export demand, supporting elevated energy infrastructure spending [16] - The EIA projects an 8% increase in natural gas demand over the next six years, indicating strong growth potential in the electrical infrastructure market [17] Company Strategy and Development Direction - The company is restructuring to create a more efficient organization, including eliminating senior positions and decentralizing business development [8][11] - Matrix is winding down its Northeast transmission and distribution service line due to competitive disadvantages, while continuing to focus on electrical infrastructure services [12][13] - The strategic focus remains on delivering sustainable long-term shareholder value through a resilient growth-oriented platform [13] Management's Comments on Operating Environment and Future Outlook - Management noted macroeconomic uncertainties due to U.S. trade and environmental policies, but believes the underlying demand environment remains strong [14] - The company revised its fiscal 2025 revenue guidance down by 10% to $770 million to $800 million, while still expecting strong year-over-year growth [15][31] - Management expressed confidence in achieving a sustainable and profitable growth trajectory, supported by a $7 billion pipeline of project opportunities [17] Other Important Information - The company reported a backlog increase of nearly 8% sequentially to over $1.4 billion, with a book-to-bill ratio of 1.5 [18] - Cash flow from operating activities was $31.2 million for Q3 and $76.8 million year-to-date, with available liquidity increasing to $247.1 million [30] Q&A Session Summary Question: Can you walk us through the decision-making process to exit the transmission and distribution business? - Management indicated that competitive dynamics made it difficult to win work at acceptable margins, leading to the decision to wind down the business without a positive backlog [35][36] Question: What are the potential cost savings from exiting the business? - The exit will result in cost savings and reallocation of resources to the electrical instrumentation business, with the business operating at a loss previously [38] Question: Are the revenue guidance adjustments due to deferrals or cancellations? - Management clarified that some revenue was deferred due to delays in contract negotiations and project awards, but they expect strong spending on energy infrastructure in the coming years [39][42] Question: What is the opportunity profile for smaller projects as the company reengages in them? - Management emphasized the importance of smaller projects for building client relationships and strengthening execution teams, indicating a need to pursue these opportunities more effectively [43][44] Question: How might the geopolitical macroeconomic environment influence customer spending? - Management expressed confidence that despite uncertainties, the global demand for energy will continue to rise, supporting infrastructure investments [51][53]

InfuSystem Holdings (INFU) Q1 2025 Earnings Call May 08, 2025 09:00 AM ET Company Participants Joe Dorame - Managing PartnerRichard DiIorio - CEOCarrie Lachance - President, COO & DirectorBarry Steele - Executive VP & CFO Conference Call Participants Brooks O'Neil - Senior Research AnalystTollef Kohrman - Associate AnalystJim Sidoti - AnalystAnderson Schock - Research Analyst Operator Good day, and welcome to the InfuSystem Holdings, Inc. Reports First Quarter twenty twenty five Financial Results Conference ...

InfuSystem Holdings (INFU) Q1 2025 Earnings Call May 08, 2025 09:00 AM ET Speaker0 Good day, and welcome to the InfuSystem Holdings, Inc. Reports First Quarter twenty twenty five Financial Results Conference Call. All participants will be in listen only mode. Should you need assistance, please signal a conference specialist by pressing the star key followed by zero. After today's presentation, there will be an opportunity to ask questions. To ask a question, you may press then 1 on your touch tone phone. To ...

Financial Data and Key Metrics Changes - Revenue for Q1 2025 was $36.3 million, down 26% year over year and down 18% in constant currency, primarily due to lower corporate sales in Egypt and currency devaluation [19][36]. - Adjusted EBITDA loss was $15.7 million in Q1 2025, compared to a loss of $4.3 million in Q1 2024 [19][41]. - Loss before income tax was $16.5 million, a significant improvement from $39.6 million in the same period last year [19][41]. Business Line Data and Key Metrics Changes - Marketplace revenue for Q1 was $18.1 million, down 30% year over year [36]. - Revenue from first-party sales was $17.8 million, down 21% year over year [36]. - Fulfillment expense per order decreased to $2.07, down 14% year over year, indicating improved efficiency [39][11]. Market Data and Key Metrics Changes - GMV declined 11% year over year, primarily due to currency headwinds and lower corporate sales, particularly in Egypt [16][19]. - Excluding corporate sales, GMV would have grown 10% year over year, highlighting strengths in the consumer business [16][19]. - Physical Goods orders grew 21% year over year, driven by strong demand [15][19]. Company Strategy and Development Direction - The company aims to reduce losses, drive efficiency, and deliver measurable financial improvements, with a focus on margin expansion and financial discipline [6][7]. - Jumia is expanding its logistics network to monetize its infrastructure beyond the core marketplace, which is expected to enhance cost efficiency [28][62]. - The company is targeting profitability by 2027, with a loss before income tax forecasted to improve significantly in 2026 [9][45]. Management's Comments on Operating Environment and Future Outlook - Management noted that while currency headwinds have impacted profitability, they expect to see improved growth trends moving forward as these effects have lapped [18][32]. - The company remains confident in its strategy and believes it is well-positioned to capture supply from Asia as global trade dynamics shift [32][56]. - Management emphasized the importance of operational discipline and cost management in achieving sustainable growth [43][33]. Other Important Information - The company has reduced its total headcount by about 3% as part of its cost control measures [11]. - Jumia's liquidity position at the end of Q1 was $110.7 million, including cash and cash equivalents [42]. - The company remains debt-free, with borrowing related solely to lease liabilities [43]. Q&A Session Summary Question: Can you explain the relationship between orders and GMV? - Corporate sales are typically high-value orders that generate significant GMV with few orders, leading to a disconnect when corporate sales decrease [49]. Question: How should we think about cash use from inventory levels? - A significant part of cash burn is due to increased working capital for inventory ahead of major campaigns, but lower impacts are expected in the coming quarters [54]. Question: Have you seen an uptick in supply from Asia? - There has been a strong trend in item sales from international vendors, particularly from China, with a 61% increase in gross items sold [55]. Question: What is the monetization strategy for the Jumia delivery business? - The delivery business is designed to be higher margin and lower volume compared to marketplace revenue, with profitability from day one [90]. Question: How significant is the deliveries business to revenue for Ivory Coast? - The deliveries business is profitable but lower than marketplace revenues, with potential for further scaling [93].

Financial Data and Key Metrics Changes - Revenue for Q1 2025 was $36.3 million, down 26% year over year and down 18% in constant currency, primarily due to lower corporate sales in Egypt and currency devaluation [33][34] - Adjusted EBITDA loss was $15.7 million in Q1 2025 compared to a loss of $4.3 million in Q1 2024, while loss before income tax improved to $16.5 million from $39.6 million year over year [17][39] - Cash burn for the quarter was $23.2 million, including $8 million in working capital, with expectations to significantly reduce cash burn in upcoming quarters [13][40] Business Line Data and Key Metrics Changes - Physical Goods orders grew 21% year over year, with quarterly active customers ordering Physical Goods increasing by 15% year over year, marking the highest growth rates in two years [14][15] - GMV declined 11% year over year, primarily due to currency headwinds and lower corporate sales, but would have grown 10% year over year excluding corporate sales [15][16] - Fulfillment expense per order decreased to $2.07, down 14% year over year, reflecting improved efficiency [10][37] Market Data and Key Metrics Changes - In Q1 2025, Ivory Coast, Nigeria, Kenya, and Egypt represented approximately 26%, 22%, 15%, and 10% of company GMV respectively, with other markets contributing 27% [20] - Nigeria saw Physical Goods orders grow by 22% and GMV increase by 18% year over year, while Kenya experienced a 36% growth in Physical Goods orders [21][22] - Egypt's Physical Goods orders were down 15% year over year, with GMV decreasing 69% in USD, primarily due to a decline in corporate sales [23] Company Strategy and Development Direction - The company aims to reduce losses, drive efficiency, and deliver measurable financial improvements, with a focus on margin expansion and financial discipline [5][6] - A comprehensive restructuring plan was launched in early 2024 to address operational challenges, particularly in Egypt [23] - The company is expanding its logistics platform to monetize its infrastructure beyond the core marketplace, targeting third-party sellers and social commerce merchants [25][60] Management's Comments on Operating Environment and Future Outlook - Management noted that while currency headwinds have impacted profitability, they expect a cleaner year-over-year comparison moving forward as these effects have lapped [16][34] - The company anticipates continued momentum in Q2 2025, with expectations for Physical Goods orders growth in the range of 20% to 25% [43][44] - Management remains confident in achieving profitability by Q4 2026 and full-year profitability in 2027, driven by cost management and volume increases [44][72] Other Important Information - The company has renegotiated or terminated several key software and hosting contracts, expecting significant cost savings starting in the second half of 2025 [11][38] - The liquidity position at the end of Q1 2025 was $110.7 million, with no financial debt, reflecting a strong cash position [40][41] Q&A Session Summary Question: Can you explain the relationship between orders and GMV? - Management clarified that corporate sales, which are high-value orders, significantly impact GMV, leading to a disconnect between orders and GMV [47][48] Question: How should we think about cash use from inventory levels? - Management indicated that increased working capital was primarily used to build up inventories ahead of significant commercial events, and they anticipate lower impacts from working capital in the coming quarters [51][52] Question: Have you seen an uptick in supply from Asia? - Management confirmed an uptick in international vendor sales, particularly from China, and expects this trend to continue as access to supply improves [53][54] Question: How do you plan to approach marketing as fundamentals improve? - Management stated that they are now in a position to be more aggressive with marketing in markets where fundamentals are strong, such as Nigeria [55][56] Question: What is the timeline for the logistics expansion? - Management explained that the logistics network is now stable enough to monetize outside the marketplace, with no negative impact on margins expected [60][62] Question: What is the visibility on 2026 guidance? - Management indicated that they expect to reach breakeven by Q4 2026, driven by growth and cost management efforts [72]

Novavax (NVAX) Q1 2025 Earnings Call May 08, 2025 08:30 AM ET Speaker0 Good morning, and welcome to Novavax First Quarter twenty twenty five Financial Results and Operational Highlights Conference Call. All participants will be in a listen only mode. After today's presentation, there will be an opportunity to ask questions. Please note, this event is being recorded. I'd now like to turn the conference over to Luis Sannai, Vice President, Investor Relations. Please go ahead. Speaker1 Good morning, and thank ...

Financial Data and Key Metrics Changes - Total revenue grew 22% year over year to $106.5 million in Q1 2025, driven by increased sales for VivGuard, Zejula, and NUZYRA [29][30] - Operating loss improved by 20% to $56.3 million, and adjusted loss from operations decreased by 25% to $37.1 million [16][30] - The company reaffirmed its full-year revenue guidance of $560 million to $590 million, anticipating significant sales growth in the latter part of the year [8][30] Business Line Data and Key Metrics Changes - VivGuard sales are expected to grow faster than total revenue growth, with a rebound in patient volumes observed in March and April after a seasonal decline [12][36] - Other products, including Zejula and NUZYRA, delivered sequential growth supported by NRDL access, with early contributions from OGTYRO and ZACDURO [15] - The company is preparing for upcoming NRDL cycles targeting IV renewal for gMG and initial listing of the SC formulation [14] Market Data and Key Metrics Changes - The company noted a significant opportunity in the gMG market in China, with approximately 70,000 patients, and less than 10% currently receiving newer biologic therapies [63] - The competitive landscape for gMG is expected to benefit from the introduction of new therapies, which will enhance overall market education and treatment options [63] Company Strategy and Development Direction - The company aims to expand its global R&D pipeline, with a focus on differentiated and high-potential assets, including GL1310 and other novel therapies [9][10] - Investments are being made to accelerate the global R&D pipeline, with plans to present updated Phase I data at ASCO [10][20] - The company is committed to achieving profitability by Q4 2025, leveraging operational efficiencies and a robust late-stage opportunity pipeline [30][31] Management's Comments on Operating Environment and Future Outlook - Management expressed confidence in achieving revenue targets and surpassing $2 billion by 2028, with strong momentum expected to carry into the 2030s [9] - The management team highlighted the importance of strategic initiatives to extend treatment duration and improve patient access [12][14] - The company remains optimistic about its financial position, ending Q1 with a cash position of $857.3 million [31] Other Important Information - The company is advancing its internal pipeline while also considering external opportunities for in-licensing [102][103] - Regulatory discussions with the FDA are ongoing, with no significant changes noted in the approval process despite recent leadership changes at the FDA [53][105] Q&A Session Summary Question: Can you provide more color on VIBGART's sequential change? - Management indicated that the sequential decline was influenced by seasonality and inventory dynamics, with confidence in recovery based on strong patient volumes in April [33][36] Question: Are you comfortable with consensus estimates for VIBGART and fiscal year revenues? - Management reaffirmed their revenue guidance and expressed confidence that VIBGART sales would grow faster than overall business rates [42][44] Question: How do recent FDA changes impact Zai Lab? - Management noted no anticipated impact from tariffs and indicated that FDA interactions have remained productive [50][53] Question: What is the competitive landscape for gMG in China? - Management believes that new approvals will benefit the market and enhance treatment options for patients [63] Question: What is the strategy regarding in-house developed assets? - The company plans to maintain a balanced approach between in-house development and external licensing opportunities [102][103]

NASDAQ:ZLAB | HKEX:9688 © 2025. Zai Lab. All Rights Reserved. Forward-Looking Statements This presentation contains forward-looking statements, including statements relating to our strategy and plans; potential of and expectations for our business, commercial products, and pipeline programs; our goals, objectives, and priorities and our expectations under our growth strategy (including our expectations regarding our commercial products and launches, clinical stage products, revenue growth / CAGR, profitabil ...

Financial Data and Key Metrics Changes - Revenue for the first quarter was $29.8 million, reflecting a 6% growth from the first quarter of the previous year [6][21] - Recurring revenue grew 20% year-over-year to $22.7 million [7][22] - Non-GAAP gross margin was 37.6%, an increase of 650 basis points from 31.1% in the prior year [9][22] - Non-GAAP operating loss was $13.4 million, 40% lower than the previous year, marking the lowest level since the company went public [24] Business Line Data and Key Metrics Changes - Console revenue grew 23% sequentially, reaching $7.1 million [21] - Consumable revenue was $14.2 million, contributing to a total product revenue of $21.3 million, which grew 4% from the prior year [21] - Service and other revenue increased by 9% to $8.5 million [22] Market Data and Key Metrics Changes - The company saw strong utilization across the Tableau installed base, contributing to recurring revenue growth [7][10] - The installed base performed over 1 million treatments annually, with significant potential for additional recurring revenue [17] Company Strategy and Development Direction - The company is focused on three priorities for 2025: growing console revenue, increasing gross margin, and driving towards profitability [18][19] - The strategy includes expanding the installed base and leveraging operational efficiencies to achieve a gross margin milestone of 50% [19][25] - The company is optimistic about its competitive advantages in both acute and home settings, emphasizing the clinical and financial benefits of insourcing with Tableau [15][16] Management's Comments on Operating Environment and Future Outlook - Management expressed confidence in the pipeline and market demand, noting that insourcing with Tableau remains compelling for healthcare providers [12][20] - The company is closely monitoring the economic environment but has not observed any negative impacts on hospital capital spending to date [48][50] - Management remains conservative in guidance, expecting revenue growth to build throughout the year [68] Other Important Information - The company successfully completed a recapitalization and is focused on aligning employee interests with those of investors [14] - The company has received tariff exemptions for its medical devices, ensuring no impact from proposed tariffs [15] Q&A Session Summary Question: Details on the turnaround in the console selling process - Management noted significant progress in the sales transformation and strong customer demand, with expectations that the transformation will be complete in the first half of 2025 [30][34] Question: Risk of macro headwinds affecting hospitals - Management indicated that there have been no observed changes in hospital capital spending and emphasized the tangible savings Tableau provides [48][50] Question: Guidance adjustments and business momentum - Management chose not to adjust guidance despite a strong quarter, maintaining a conservative approach while expecting sequential revenue growth [64][68] Question: Console installed base growth - Management confirmed console revenue increased by 23% from the previous quarter, with strong performance in treatments [74]